Eton Pharmaceuticals Inc (ETON) Live Share Price, Invest From India

Eton Pharmaceuticals Inc Stock Performance

as on May 7, 2026 at 5:11 am IST

Day's Low
Day's High
$30.37
Day's Price Range
$31.49
$30.50
0.43%
Downside
3.25%
Upside
52 Week's Low
52 Week's High
$13.09
52-Week Price Range
$32.31
$30.50
57.10%
Downside
5.93%
Upside

Eton Pharmaceuticals Inc share price movements today

Previous Close: $30.38
Open: $30.80
Volume: 391.8K
Day's Low - High: $30.37 - $31.49
52 Week Low - High: $13.09 - $32.31

Eton Pharmaceuticals Inc Historical Returns

1 Month Return: + 21.52 %
3 Month Return: + 105.83 %
1 Year Return: + 82.68 %
3 Year Return: 0 %
5 Year Return: 0 %

Eton Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Eton Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$831.2M

EPS (TTM)

1.03

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.13%

PE Ratio (TTM)

PEG Ratio

EBITDA

8.9M

Revenue (TTM)

80.0M

Profit Margin

-5.76%

Return On Equity TTM

-18.19%

Eton Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Eton Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Eton Pharmaceuticals Inc	BUY	$831.2M	NA	NA	-5.76%
United Therapeutics Corporation	BUY	$24.3B	NA	20.54	41.94%
Viatris Inc	HOLD	$17.7B	11.41%	NA	-24.58%
Haleon plc	BUY	$40.7B	NA	18.34	15.11%
Zoetis Inc	BUY	$47.5B	-32.82%	18.69	28.24%

Stock Returns calculator for Eton Pharmaceuticals Inc Stock including INR - Dollar returns

The Eton Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Eton Pharmaceuticals Inc investment value today

Current value as on today

₹2,05,822

Returns

₹1,05,822

(+105.82%)

Returns from Eton Pharmaceuticals Inc Stock

₹83,403 (+83.4%)

Dollar Impact

₹22,418 (+22.42%)

Analyst Recommendation on Eton Pharmaceuticals Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Eton Pharmaceuticals Inc. Average target price of $41

Eton Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Eton Pharmaceuticals Inc.

What analysts predicted

25.61%UPSIDE

Target Price

$41

Current Price

$30.5

Analyzed by

7 Analysts

Target

$41.00

Eton Pharmaceuticals Inc target price $41, a slight upside of 25.61% compared to current price of $30.5. According to 7 analysts rating.

Indian Investors' Interest in Eton Pharmaceuticals Inc Stock

Search interest for Eton Pharmaceuticals Inc Stock has increased by 118% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 6, 2026 to May 6, 2026

Change:118% versus previous 30 day period

Eton Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	7	7	7	9	10	11	17	18	22	21
Gross Profit	4	3	5	5	6	6	9	11	7	13
Operating Income	0	-1	0	-2	0	0	0	-1	-1	2
EBITDA	0	-2	0	-2	0	0	0	0	0	3
Interest Expense	0	0	0	0	0	1	1	1	1	1
Depreciation	0	0	0	0	0	0	1	1	1	1
Income Before Tax	0	-2	0	-2	0	0	-1	-2	-1	1
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	0	-2	0	-3	0	0	-1	-2	-1	1
Net Profit Margin	-8.24%	-30.85%	-10.18%	-33.51%	6.07%	-5.13%	-9.10%	-13.66%	-8.58%	6.97%

Eton Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	0	0	21	21	31	39	79
Gross Profit	0	0	0	0	19	14	21	23	42
Operating Income	-7	-10	-18	-27	-1	-8	-1	-2	0
EBITDA	-7	-10	-18	-26	-1	-6	0	-1	4
Interest Expense	-	0	0	0	1	0	1	2	4
Depreciation	-	0	0	0	0	1	0	1	4
Income Before Tax	-7	-12	-18	-27	-1	-9	0	-3	-4
Income Tax Expense	-	-2	0	0	1	0	0	0	0
Net Income	-7	-12	-18	-27	-1	-9	0	-3	-4
Net Profit Margin	0.00%	0.00%	-1910.32%	-71717.95%	-8.95%	-42.45%	-2.96%	-9.80%	-5.75%

Eton Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-2	0	-3	0	0	-1	-2	-1	1
Operating Cash Flow	0	-2	1	2	0	2	7	12	-11
Investing Cash Flow	0	-1	-	1	-38	-	-	0	0
Financing Cash Flow	0	0	0	0	33	0	-	-	0
Change in Cash	0	-4	1	2	-5	2	7	11	-11

Eton Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-12	-18	-27	-1	-9	0	-3	-4
Operating Cash Flow	-8	-18	-22	-4	4	6	0	10
Investing Cash Flow	0	-1	0	-2	-2	0	-40	0
Financing Cash Flow	21	5	31	0	0	0	32	0
Change in Cash	13	-14	9	-6	1	5	-6	11

Global Institutional Holdings in Eton Pharmaceuticals Inc

Funds	Holdings
BlackRock Inc	6.25%
EcoR1 Capital, LLC	7.42%
Vanguard Group Inc	4.93%
BNP Paribas Arbitrage, SA	1.01%
UBS Group AG	0.81%

See all

Insights on Eton Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -2.58M → 1.48M (in $), with an average increase of 132.0% per quarter
POSITIVE IMPACT
Price Rise
In the last 7 days, ETON stock has moved up by 28.8%
NO EFFECT
Against Peers
In the last 1 year, United Therapeutics Corporation has given 94.0% return, outperforming this stock by 11.3%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 22.45M → 21.28M (in $), with an average decrease of 5.3% per quarter

About Eton Pharmaceuticals Inc

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Organisation	Eton Pharmaceuticals Inc
Headquarters	21925 W. Field Parkway, Deer Park, IL, United States, 60010-7278
Industry	Drug Manufacturers - Specialty & Generic
CEO	Mr. Sean E. Brynjelsen
E-voting on shares	Click here to vote

Key Management of Eton Pharmaceuticals Inc

Name	Title
Mr. David C. Krempa	Chief Business Officer
Ms. Ipek Erdogan-Trinkaus	Chief Commercial Officer
Danka Radosavljevic	Executive Vice President of Operations
Ms. Judith M. Matthews	Executive Vice President of Accounting & Finance
Mr. Scott Grossenbach	Senior Vice President of Sales Operations
Mr. Sean E. Brynjelsen	President, CEO & Director

FAQs

What is Eton Pharmaceuticals Inc share price today?

Eton Pharmaceuticals Inc share price today is $30.5 as on May 6, 2026 at 11:41 pm IST. Eton Pharmaceuticals Inc share today touched a day high of $31.49 and a low of $30.37.

What is the 52 week high and 52 week low for Eton Pharmaceuticals Inc share?

Eton Pharmaceuticals Inc share touched a 52 week high of $32.31 on May 5, 2026 and a 52 week low of $13.09 on June 25, 2025. Eton Pharmaceuticals Inc stock price today i.e. May 6, 2026 at 11:41 pm IST is trending at $30.5,which is 5.60% down from its 52 week high and 133.09% up from its 52 week low.

What is Eton Pharmaceuticals Inc's market capitalisation today?

Eton Pharmaceuticals Inc market capitalisation is $0.00T as on May 6, 2026 at 11:41 pm IST.

How to invest in Eton Pharmaceuticals Inc Stock (ETON) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Eton Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Eton Pharmaceuticals Inc Shares that will get you 0.0492 shares as per Eton Pharmaceuticals Inc share price of $30.5 per share as on May 6, 2026 at 11:41 pm IST.

What is the minimum amount required to buy Eton Pharmaceuticals Inc Stock (ETON) from India?

Indian investors can start investing in Eton Pharmaceuticals Inc (ETON) shares with as little as ₹94.61 or $1 (as of May 6, 2026 at 11:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹946.10 in Eton Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on May 6, 2026 at 11:41 pm IST). Based on Eton Pharmaceuticals Inc share’s latest price of $30.5 as on May 6, 2026 at 11:41 pm IST, you will get 0.3279 shares of Eton Pharmaceuticals Inc. Learn more about fractional shares .